Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Oncolytics Biotech, Inc. (NQ: ONCY)
2.260 USD  -0.080 (-3.42%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Oncolytics Biotech, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Oncolytics Biotech® Inc. to Present at 2013 Jefferies Global Healthcare Conference
June 04, 2013
from PR Newswire
Free Research Reports on GILD, MRK, ONCY and PFE Issued by the Bedford Report
May 23, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
ONC.CA Makes Bullish Cross Above Critical Moving Average
May 22, 2013
In trading on Wednesday, shares of Oncolytics Biotech Incorporated (ONC) crossed above their 200 day moving average of $2.94, changing hands as high as $3.15 per share. Oncolytics Biotech Incorporated... Read More
category Dividends
from Dividend Channel
Oncolytics cancer drug meets mid-stage trial goal, shares rise
May 22, 2013
May 22 (Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with... Read More
category companyNews
from Reuters: Company News
StreetInsider.com Pre-Open Movers 5/22: (ZLC) (SKS) (TOL) Higher; (UAN) (TGT) (SODA) Lower (more...)
May 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8361494 for the full story. Read More
from StreetInsider.com News Articles
Oncolytics Announces First Stage of Metastatic Melanoma Phase 2 Trial Meets Primary Endpoint
May 22, 2013
Oncolytics Biotech Inc. ("Oncolytics") (NASDAQ: ONCY ) today announced preliminary results from its U.S. Phase 2 clinical trial in patients with metastatic melanoma using intravenous administration of... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Oncolytics Biotech (ONCY) REOLYSIN w/ REO 020 Met Primary Endpoint in Phase 2
May 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8360594 for the full story. Read More
from StreetInsider.com News Articles
Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial
May 22, 2013
from PR Newswire
Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care Conference
May 14, 2013
from PR Newswire
Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of Shareholders
May 10, 2013
from PR Newswire
Oncolytics Biotech (ONCY) Posts Q1 Loss of 8c/Share
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8320336 for the full story. Read More
from StreetInsider.com News Articles
Oncolytics Biotech® Inc. Announces First Quarter 2013 Results
May 09, 2013
from PR Newswire
Oncolytics Biotech® Inc. Announces Details of 2013 Annual and Special Meeting of Shareholders
May 06, 2013
from PR Newswire
Media Advisory - Oncolytics Biotech® Inc. to Present at 12th Annual Needham Healthcare Conference
April 29, 2013
from PR Newswire
NASDAQ Gainers Watch List: DARA BioSciences, Inc (NASDAQ:DARA) and Oncolytics Biotech Inc. (NASDAQ:ONCY) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 22, 2013
New York, NY -- (SBWIRE) -- 04/22/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding DARA BioSciences, Inc (NASDAQ:DARA) and Oncolytics Biotech Inc. (NASDAQ:ONCY). Read More
from SBWire - Latest Press Releases
Free Research Reports on FINL, ONCY, PCS and RPRX Issued by the Bedford Report
April 01, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Hot Stocks: Cell Therapeutics, Oncolytics Biotech, Excel Maritime Carriers, Deckers Outdoor
March 28, 2013
Lakeway, NY -- (SBWIRE) -- 03/28/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
StreetInsider.com Pre-Open Movers 03/28: (RPRX) (DECK) (XONE) Higher; (FIVE) (RHT) (GME) Lower (more...)
March 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8217417 for the full story. Read More
from StreetInsider.com News Articles
Oncolytics (ONCY) REOLYSIN Met Primary Endpoint in Phase 2 on SCCLC
March 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8216741 for the full story. Read More
from StreetInsider.com News Articles
Oncolytics Biotech® Inc. Meets Primary Overall Statistical Endpoint in U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer
March 28, 2013
from PR Newswire
NASDAQ Decliners Watch List: ARCA biopharma, Inc. (NASDAQ:ABIO), Oncolytics Biotech Inc. (NASDAQ:ONCY), and Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Added to Growing Stock Report's NASDAQ Decliner
March 27, 2013
New York, NY -- (SBWIRE) -- 03/27/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding ARCA biopharma, Inc. (NASDAQ:ABIO), Oncolytics Biotech Inc. (NASDAQ:ONCY), and... Read More
from SBWire - Latest Press Releases
News Review: Pacific Biosciences of California, DARA Biosciences Inc, Oncolytics Biotech, BioCryst Pharmaceuticals
March 19, 2013
Lakeway, TX -- (SBWIRE) -- 03/19/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval after Just 1 Round of Testing
March 19, 2013
Five Star Equities Provides Stock Research on Oncolytics Biotech and XOMA Read More
from Marketwired News Releases
Oncolytics Biotech® Inc. Announces 2012 Year End Results
March 14, 2013
from PR Newswire
ONC.CA Makes Notable Cross Below Critical Moving Average
March 13, 2013
In trading on Wednesday, shares of Oncolytics Biotech Incorporated (ONC) crossed below their 200 day moving average of $3.08, changing hands as low as $3.06 per share. Oncolytics Biotech Incorporated... Read More
category Dividends
from Dividend Channel
Stocks Buzz: Teradata Corporation, Oncolytics Biotech, CenturyLink, ResMed Inc
March 08, 2013
Dallas, TX -- (SBWIRE) -- 03/08/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Oncolytics Biotech Inc. (NASDAQ:ONCY) and KiOR, Inc. (NASDAQ:KIOR) Added to Growing Stock Report's NASDAQ Decliners Watch List.
March 06, 2013
New York, NY -- (SBWIRE) -- 03/06/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Oncolytics Biotech Inc. (NASDAQ:ONCY) and KiOR, Inc. (NASDAQ:KIOR) Read More
from SBWire - Latest Press Releases
Oncolytics (ONCY) Completes Enrollment in REOLYSIN Phase 2
March 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8155035 for the full story. Read More
from StreetInsider.com News Articles
Oncolytics Biotech® Inc. Completes Patient Enrollment in U.S. Phase 2 Study of REOLYSIN® in Non-Small Cell Lung Cancer
March 05, 2013
from PR Newswire
Eleven Stocks Expected to Rise by 50% to 100% — or More
March 05, 2013
DailyFinance.com : Investors are always looking for new ideas. Now that the Dow Jones Industrial Average is trying to hit new highs and investors are pouring record inflows of capital into stocks,... Read More
category sqnm , btu , for , and 8 more.
from DailyFinance.com
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here